Skip to main content
. 2025 Nov 29;17(23):3842. doi: 10.3390/cancers17233842
A. muciniphila Akkermansia muciniphila
ADT Androgen deprivation therapy
AR Androgen receptor
AHR Aryl hydrocarbon receptor
CRPC Castration-resistant prostate cancer
Dehydroepiandrosterone DHEA
FMT Fecal microbiota transplantation
GI Gastrointestinal
GZMB Granzyme B
GM Gut microbiome
HFD High-fat diet
HSPC Hormone-sensitive prostate cancer
ICI Immune checkpoint inhibitors
IGF-1 Insulin-like growth factor 1
IL-2 Interleukin-2
IL-6 Interleukin-6
IL-12 Interleukin-12
LPS Lipopolysaccharide
mTOR Mechanistic target of rapamycin
NK Natural killer
PAMPs Pathogen-associated molecular patterns
PRRs Pattern-recognition receptors
PD Pharmacodynamics
PK Pharmacokinetics
PTEN Phosphatase and tensin homolog
PI3K Phosphatidylinositol 3-kinase
PAHs Polycyclic aromatic hydrocarbons
PIA Proliferative inflammatory atrophy
PIN Prostatic intraepithelial neoplasia
PSA Prostate specific antigen
SCC Prostatic small cell carcinoma
AKT Protein kinase B
RT Radiotherapy
SCFAs Short-chain fatty acids
TPH1 Tryptophan hydroxylase 1
TNF Tumor necrosis factor
TME Tumor-promoting microenvironment